Dear David, This is your 20th anniversary with the CHS and we would like to take this time to extend our deepest gratitude for all...
Mild hemophilia can be very serious and even life-threatening if injuries or bleeds are not treated promptly and adequately. The past few years, a lot...
by David Page, CHS National Director of Health Policy Given recent advances in therapies for inherited bleeding disorders, especially hemophilia A and B, I have...
Montreal, December 16, 2021 – The rollout of emicizumab (Hemlibra) in the provinces and territories served by Canadian Blood Services (CBS) is well underway. Emicizumab...
November 10, 2021 (Montreal) – The Hemlibra rollout continues in provinces served by Canadian Blood Services (CBS). Since access requests from physicians began to be...
